Ghislaine Gilleron
Geen lopende functies
Profiel
Ghislaine Gilleron is the founder of ElsaLys Biotech SAS, which was founded in 2013.
She worked as a Director at MiddleNext and as General Secretary & General Counsel at Transgene SA in 1985.
Ms. Gilleron completed her undergraduate degree at Institut d'Études Politiques d'Aix-en-Provence.
Eerdere bekende functies van Ghislaine Gilleron
| Bedrijven | Functie | Einde |
|---|---|---|
MiddleNext
 MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Directeur/Bestuurslid | - |
| ELSALYS BIOTECH | Oprichter | - |
| TRANSGENE | Algemeen Adviseur | 01-01-1985 |
Opleiding van Ghislaine Gilleron
| Institut d'Études Politiques d'Aix-en-Provence | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MiddleNext
MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |